Almohareb et al. [117] conducted a multicenter retrospective study that aimed to assess the safety and efficacy of GLP-1 RAs in T1D patients (older than 16 years) based on real-world data. The gene discussed is GLP1R; the disease is type 1 diabetes mellitus.